Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-68.92M -61.33M -60.33M -66.72M -69.65M -62.05M -59.66M -61.9M -65.7M -58.34M -66.72M -57.76M -54.4M -42.98M -44.25M -50.12M -34.52M -40.18M
Depreciation & Amortization
2.58M 2.99M 2.36M 2.42M 2.37M 2.25M 1.94M 1.76M 1.73M 1.67M 3.38M 1.08M 496K 1.3M 3.19M 808K 706K 674K
Stock-Based Compensation
10.86M 10.33M 11.09M 11.25M 11.33M 10.25M 9.93M 10.32M 10.24M 8.91M 9.69M 7.68M 7.37M 6.27M 7.04M 6.99M 7.31M 7.9M
Other Working Capital
8.73M -5.7M -732K 248K 4.33M -4.58M 21.53M -5.94M 5.34M 7.75M -6.96M 4.45M 3.34M -3.94M 1.65M 6.08M -14.11M -934K
Other Non-Cash Items
-2.21M -2.08M 668K 699K -2.24M -2.75M 9.39M -13.85M -2.49M -2.34M -2.54M 690K 1.61M 617K 5.2M 7.63M 116K 589K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.47M 12.47M n/a n/a n/a n/a n/a n/a 1.06M 743K 726K 620K
Change in Working Capital
8.73M -5.7M -732K 248K 4.33M -4.58M 21.53M -5.94M 5.34M -7.47M 170K 4.45M 5.89M -4.43M -3.18M 6.54M -12.86M 6.11M
Operating Cash Flow
-48.96M -55.79M -46.94M -52.1M -53.85M -56.88M -29.34M -57.15M -50.87M -57.56M -56.02M -43.86M -39.04M -39.22M -30.94M -27.41M -38.53M -24.28M
Capital Expenditures
-50K -364K -309K -1.59M -1.93M -2.04M -4.65M -4.66M -4.15M -3.02M -3.26M -503K -2.9M -1.96M -2.04M -3.84M -1.51M -328K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 81.23K -52.91K -35.33K 7K 42.73M -23.97K n/a n/a 95K 423K 325K n/a
Purchase of Investments
-52.69M -139.93M -124.05M -19.32M -38.57M -63.95M -208.5M -13.49M -72.9M -96.03M -198.87M -34.44M -143.02M -143.02M -19.39M -67.91M -54.76M -103.81M
Sales Maturities Of Investments
84.5M 82.26M 86.48M 99.83M 96.13M 101.02M 72.34M 66.4M 108.25M 62.34M 50.82M 58.41M 81.69M 81.98M 38.3M 53.56M 105.61M 74.97M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -81.23K 52.91K 35.33K -7K -148.31K 23.97K 143.02M -61.04K -95K -423K -325K -28.85K
Investing Cash Flow
31.76M -58.03M -37.87M 78.92M 55.62M 35.03M -140.81M 48.25M 31.21M -36.72M -108.58M 23.46M 78.79M -62.99M 16.86M -18.19M 49.35M -29.17M
Debt Repayment
13K 12K -56K 24K 29K 27K 30K 35K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -47K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-13K n/a 56K -24K n/a n/a -30K -35K n/a 7K 631K n/a n/a n/a 1.14M n/a n/a n/a
Financial Cash Flow
215K 12K 182.85M 176K 1.56M 1.21M 391K 189.49M 182K 18.34M 108.44M 29.53M 17.25M 76K 1.14K 26.64K 1.11K 8.79K
Net Cash Flow
-16.99M -113.83M 98.04M 26.99M 3.33M -20.63M -169.75M 180.59M -19.48M -75.94M -56.17M 9.13M 57M -102.14M -12.94M -18.96M 11.94M -44.66M
Free Cash Flow
-49.01M -56.15M -47.25M -53.69M -55.78M -58.92M -33.99M -61.8M -55.02M -60.58M -59.28M -44.36M -41.94M -41.18M -32.98M -31.25M -40.03M -24.61M